Synthesis, characterization and biological evaluation of benzothiazoles and tetrahydrobenzothiazoles bearing urea or thiourea moieties as vasorelaxants and inhibitors of the insulin releasing process
Harrouche, K; Renard, JF; Bouider, Net al.
2016 • In European Journal of Medicinal Chemistry, 115, p. 352-360
De Tullio, Pascal ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Goffin, Eric ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Lebrun, P
Faury, G
Pirotte, Bernard ; Université de Liège > Département de pharmacie > Chimie pharmaceutique
Khelili, S
Language :
English
Title :
Synthesis, characterization and biological evaluation of benzothiazoles and tetrahydrobenzothiazoles bearing urea or thiourea moieties as vasorelaxants and inhibitors of the insulin releasing process
L. Aguilar-Bryan, and J. Bryan Molecular biology of adenosine triphosphate-sensitive potassium channels Endocr. Rev. 20 1999 101 135
M.J. Coghlan, W.A. Carroll, and M. Gopalakrishan Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress J. Med. Chem. 44 2001 1627 1653
S. Seino, N. Inagaki, N. Namba, C.H. Wang, K. Kotake, K. Nagashima, T. Miki, L. Aguilar-Bryan, J. Bryan, and T. Gonoi Molecular basis of functional diversity of ATP-sensitive K+ channels Jpn. J. Physiol. 47 1997 S3
M.A. Burke, R.K. Mutharasan, and H. Ardehali The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel Circ. Res. 102 2008 164 176
F.M. Ashcroft, and S.J.H. Ashcroft Properties and functions of ATP-sensitive K-channels Cell Signal 2 1990 197 214
J.M. Quayle, M.T. Nelson, and N.B. Standen ATP-sensitive and inwardly rectifying potassium channels in smooth muscle Physiol. Rev. 77 1997 1165 1232
A. Fujita, and Y. Kurachi Molecular aspects of ATP-sensitive K+ channels in the cardiovascular system and K+ channel openers Pharmacol. Ther. 85 2000 39 53
F.M. Ashcroft, and M. Gribble Correlating structure and function in ATP-sensitive K+ channels Trends Neurosci. 21 1998 288 294
G. Edwards, and A.H. Weston The pharmacology of ATP-sensitive potassium channels Annu. Rev. Pharm. Toxicol. 33 1993 597 637
P. de Tullio, B. Pirotte, P. Lebrun, J. Fontaine, L. Dupont, M.-H. Antoine, R. Ouedraogo, S. Khelili, C. Maggetto, B. Masereel, O. Diouf, T. Podona, and J. Delarge 3- and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium channel openers: synthesis, pharmacological evaluation, and structure-activity relationships J. Med. Chem. 39 1996 937 948
P. Lebrun, P. Arkhammar, M.H. Antoine, Q.A. Nguyen, J.B. Hansen, and B. Pirotte A potent diazoxide analogue activating ATP-sensitive K+ channels and inhibiting insulin release Diabetologia 43 2000 723 732
F.E. Nielsen, T.B. Bodvarsdottir, A. Worsaae, P. MacKay, C.E. Stidsen, H.C. Boonen, L. Pridal, P.O. Arkhammar, P. Wahl, L. Ynddal, F. Junager, N. Dragsted, T.M. Tagmose, J.P. Mogensen, A. Koch, S.P. Treppendahl, and J.B. Hansen 6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP-sensitive potassium channels of pancreatic beta-cells J. Med. Chem. 45 2002 4171 4187
B. Pirotte, P. de Tullio, P. Lebrun, M.H. Antoine, J. Fontaine, B. Masereel, M. Schynts, L. Dupont, A. Herchuelz, and J. Delarge 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic β-cells: a new class of potassium channel openers? J. Med. Chem. 36 1993 3211 3213
A. Fischer, C. Schmidt, S. Lachenicht, D. Grittner, M. Winkler, T. Wrobel, A. Rood, H. Lemoine, W. Frank, and M. Braun Synthesis of benzofuran, benzothiophene and benzothiazole-based thioamides and their evaluation as KATP channel openers ChemMedChem. 5 2010 1749 1759
S. Khelili, G. Leclerc, G. Faury, and J. Verdetti Synthesis and vasodilator effects of 3- and 7-sulfonylurea-1,2,4-benzothiadiazin-1,1-dioxides on rat aorta Bioorg. Med. Chem. 3 1995 495 503
J.A. Lin, and S. Kasina Synthesis of 3-substituted 7-(3,3-dimethyl-1-triazeno)-10-methylphenothiazines as potential antitumor agents J. Heterocycl. Chem. 18 1981 759 761
R.L. Mital, and K.S. Jain Synthesis of some 5-substituted 2-aminobenzenethiols and their conversion into phenothiazines via smiles rearrangement J. Chem. Soc. 16 1969 2148 2150
A.R. Hantzsch, and J.H. Weber Ueber verbindungen des thiazols (pyridins der thiophenreihe) Ber. Dtsch. Chem. Ges. 20 1887 3118 3132
L.C. King, and R. Hlavacek The reaction of ketones with iodine and thiourea J. Am. Chem. Soc. 72 1950 3722 3725
P. Lebrun, Z.-Y. Fang, M.-H. Antoine, A. Herchuelz, M. Hermann, G. Berkenboom, and J. Fontaine Hypoglycemic sulfonylureas antagonize the effects of cromakalim and pinacidil on 86Rb fluxes and contractile activity in the rat aorta Pharmacology 41 1990 36 48
M.-H. Antoine, G. Berkenboom, Z.-Y. Fang, J. Fontaine, A. Herchuelz, and P. Lebrun Mechanical and ionic response of rat aorta to diazoxide Eur. J. Pharmacol. 216 1992 299 306
P. Lebrun, M.-H. Antoine, V. Devreux, M. Hermann, and A. Herchuelz Paradoxical inhibitory effect of cromakalim on 86Rb outflow from pancreatic islet cells J. Pharmacol. Exp. Ther. 255 1990 948 954
P. de Tullio, B. Becker, S. Boverie, M. Dabrowski, P. Wahl, M.H. Antoine, F. Somers, S. Sebille, R. Ouedrago, J.B. Hansen, P. Lebrun, and B. Pirotte Toward tissue-selective pancreatic β-cells KATP channel openers belonging to 3-alkylamino-7-halo-4H-1,2,4-benzothiadiazine 1,1-dioxides J. Med. Chem. 46 2003 3342 3353
S. Boverie, M.R. Antoine, F. Somers, B. Becker, S. Sebille, R. Ouedraogo, S. Counerotte, B. Pirotte, P. Lebrun, and P. De Tullio Effect on KATP channel activation properties and tissue selectivity of the nature of the substituent in the 7- and the 3-position of 4H-1,2,4-benzothiadiazine 1,1-dioxides J. Med. Chem. 48 2005 3492 3503
P. Lebrun, B. Becker, N. Morel, P. Ghisdal, M.H. Antoine, P. de Tullio, and B. Pirotte KATP channel openers: tissue selectivity of original 3-alkylaminopyrido- and 3-alkylaminobenzothiadiazine 1,1-dioxides Biochem. Pharmacol. 75 2008 468 475
